London – As reports of self-inflicted harm and suicidal thoughts have increased among those who use Ozempic or Wegovy in Europe and the United Kingdom, health regulators are looking at potential risk of adverse effects linked to these drugs. The European Medicines Agency said it was evaluating 150 such cases. These drugs are known to reduce blood sugar levels and curb appetite by simulating a gut hormone.